Cancer
In a landmark study, researchers at the Institute for Cancer Research and Treatment (IRCCS) San Raffaele Scientific Institute have found that intravenous amino acid therapy significantly decreases the occurrence of acute kidney injury in cardiac surgery patients, particularly those with chronic kidney disease. This breakthrough research, published in the journal
Cancer
Researchers at the University of Helsinki have made significant progress in cancer gene therapy by developing a novel method for delivering mRNA to lung endothelium and immune cells, including T cells, with low in vivo toxicity. This breakthrough marks a crucial step towards effective treatment of various cancers, including lung
Cancer
Research published in Internal Medicine journal revealed a case of an 11-year-old boy who developed cardioembolic stroke (CES) and cancer therapy-related cardiac dysfunction (CTRCD) despite effective treatment with high-dose chemotherapy. The patient was admitted with severe aphasia and magnetic resonance imaging showed occlusion of the left middle cerebral artery M3
Cancer
A systematic review and meta-analysis of artificial intelligence (AI) networks has shown promising potential in predicting immunotherapy outcomes for gastrointestinal cancers based on genetic mutation features. The study, published in BMC Gastroenterology, analyzed 45 studies involving 14,047 participants and found that AI models were able to predict immunotherapy responses
Cancer
Research has shed new light on the critical role of programmed cell death (PCD) genes in gastric cancer progression and response to therapies. A team of researchers from Fujian University of Traditional Chinese Medicine, led by YinChao Guo, has developed a prognostic cell death signature (PCDs) for gastric cancer, providing
Cancer
Researchers from the National Institute of Genetic Engineering and Biotechnology in Iran have developed a novel nanocomplex, htsFLT01/MiRGD, that targets key angiogenesis markers in cancer. The study, published in Translational Oncology, demonstrates the potential of this nanocomplex in suppressing angiogenesis, inducing apoptosis, and inhibiting tumor cell proliferation. The findings
Cancer
The use of weight-loss drugs could revolutionise cancer prevention treatment, according to expert researchers. A landmark study found that these jabs can cut the risks of developing cancer by almost half, with potential transformative implications for preventative cancer medicine. This breakthrough research suggests that people at high risk of developing
Cancer
A two-year-old girl, Nancy Dakin, from Derby, was diagnosed with a cancerous brain tumour 12 months ago. Nancy's family received a grant from Young Lives vs Cancer, a charity that provides financial and emotional support to families affected by cancer. The charity's specialist social worker, Kim,
Cancer
Scientists have made a landmark discovery suggesting that a weekly jab to suppress appetite can not only lead to significant weight loss but also reduce the risk of obesity-related cancers. Researchers from Israel and the UK analyzed data from over 6,000 adults treated for obesity and type 2 diabetes,
Cancer
Researchers at Hanyang University have made a significant discovery in cancer therapy, developing fucoidan-chitosan nanocarriers that demonstrate high efficacy in reducing cancer cell viability while minimizing side effects. This innovative approach combines chemodynamic therapy, starvation therapy, and photothermal therapy to activate drug release and generate reactive oxygen species within the
Cancer
Researchers at Central South University have developed a dual signal amplification platform that utilizes size-adjustable silver nanoparticles and magnetic capture probes to selectively capture and quantitatively detect circulating tumor cells (CTCs) in breast cancer patients. This innovative approach enables direct detection of cancer cells in real human blood samples at
Cancer
Investigations into the use of Janus kinase inhibitors (JAKi) in patients with cutaneous T-cell lymphoma (CTCL) have yielded promising results, according to a study published in The Journal of Dermatology. Researchers at Memorial Sloan-Kettering Cancer Center retrospectively analyzed the experience of their tertiary cancer center with JAKi in patients seen
